Infectious Disease In Vitro Diagnostics Market Size, Share, Trends, Growth Outlook

Infectious Disease In Vitro Diagnostics Market is estimated to increase at a growth rate of 3.5% CAGR over the forecast period from 2024 to 2030.

 

The Infectious Disease In Vitro Diagnostics Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Instruments, Reagents, Software Services), By Technology (Immunoassay, Molecular Diagnostics, Microbiology), By Application (MRSA, Streptococcus, Clostridium Difficile, VRE, CRE, Respiratory Virus, Candida, TB and Drug-resistant TB, Gastro-intestinal Panel Testing, Chlamydia, Gonorrhea, HPV, HIV, Hepatitis C, Hepatitis B, COVID-19, Others), By Test Location (Point of Care, Central Laboratories, Others).

 

An Introduction to Infectious Disease In Vitro Diagnostics Market in 2024

The infectious disease in vitro diagnostics market in 2024 encompasses a diverse range of diagnostic tests and platforms designed to detect and identify pathogens responsible for infectious diseases, including bacteria, viruses, fungi, and parasites. In vitro diagnostic assays play a critical role in disease surveillance, outbreak investigation, and patient management by enabling rapid and accurate diagnosis, antimicrobial susceptibility testing, and monitoring of treatment responses. Key technologies include nucleic acid amplification tests (NAATs), immunoassays, and rapid antigen detection assays, offering benefits such as high sensitivity, specificity, and automation to enhance laboratory efficiency and patient care. Market dynamics are driven by factors such as the increasing global burden of infectious diseases, emergence of antimicrobial resistance, and technological advancements in molecular diagnostics and point-of-care testing. Collaboration between diagnostic companies, public health agencies, and healthcare providers fuels innovation in infectious disease diagnostics, leading to the development of next-generation assays with improved performance, accessibility, and cost-effectiveness that contribute to the control and prevention of infectious disease outbreaks and pandemics.

Infectious Disease In Vitro Diagnostics Market Trend: Increasing Demand for Point-of-Care Testing

A prominent trend in the Infectious Disease In Vitro Diagnostics market is the increasing demand for point-of-care testing (POCT). POCT offers rapid and accurate diagnostic results at or near the patient's location, reducing the turnaround time for diagnosis and enabling timely clinical decision-making. With the rising prevalence of infectious diseases, particularly in regions with limited access to centralized laboratory facilities, there is a growing need for portable and easy-to-use POCT devices for early detection and management of infectious pathogens. As a result, manufacturers are developing innovative POCT solutions for a wide range of infectious diseases, including HIV, influenza, malaria, tuberculosis, and sexually transmitted infections, catering to the evolving needs of healthcare providers and patients.

Infectious Disease In Vitro Diagnostics Market Driver: Increasing Incidence and Prevalence of Infectious Diseases

A key driver in the Infectious Disease In Vitro Diagnostics market is the increasing incidence and prevalence of infectious diseases worldwide. Factors such as population growth, urbanization, globalization, antimicrobial resistance, and climate change contribute to the spread of infectious pathogens, posing significant public health challenges globally. Healthcare systems are facing growing pressure to diagnose, monitor, and control infectious diseases effectively to prevent outbreaks, reduce morbidity and mortality rates, and contain healthcare costs. In response, there is a rising demand for advanced in vitro diagnostic technologies, including molecular diagnostics, immunoassays, and rapid antigen tests, to accurately identify infectious agents and guide appropriate treatment strategies, driving the market growth for infectious disease diagnostics.

Infectious Disease In Vitro Diagnostics Market Opportunity: Adoption of Multiplex Testing Platforms

An opportunity for market growth in the Infectious Disease In Vitro Diagnostics market lies in the adoption of multiplex testing platforms. Multiplex assays enable simultaneous detection and differentiation of multiple pathogens or biomarkers in a single sample, offering enhanced diagnostic capabilities, efficiency, and cost-effectiveness compared to traditional singleplex tests. Multiplex testing platforms are particularly valuable in the diagnosis of infectious diseases with similar clinical presentations or co-infections, allowing healthcare providers to streamline testing workflows, conserve sample volumes, and expedite patient management decisions. By investing in the development and commercialization of multiplex testing solutions, diagnostic companies can address the evolving needs of healthcare professionals for comprehensive and timely infectious disease diagnostics, driving market expansion and competitive differentiation.

 

Infectious Disease In Vitro Diagnostics Market Segmentation

By Product

Instruments

Reagents

Software Services

 

By Technology

Immunoassay

Molecular Diagnostics

-Polymerase Chain Reaction (PCR)

-In Situ Hybridization

-Isothermal Nucleic Acid Amplification Technology (INAAT)

-Chips and Microarrays

-Sequencing & NGS

-Transcription Mediated Amplification

Microbiology

 

By Application

MRSA

Streptococcus

Clostridium Difficile

VRE

CRE

Respiratory Virus

Candida

TB and Drug-resistant TB

Gastro-intestinal Panel Testing

Chlamydia

Gonorrhea

HPV

HIV

Hepatitis C

Hepatitis B

COVID-19

Others

 

By Test Location

Point of Care

Central Laboratories

Others

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Infectious Disease In Vitro Diagnostics Market Companies

Abbott

Becton, Dickinson and Company

bioMérieux SA

Bio-Rad Laboratories Inc

Danaher Corp

F. Hoffmann-La Roche Ltd

Hologic Inc

OraSure Technologies Inc

QIAGEN

Quidel Corp

Siemens Healthineers AG

*- List Not Exhaustive

 

Reasons to Buy the Infectious Disease In Vitro Diagnostics Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions

• Gain access to detailed insights on the Infectious Disease In Vitro Diagnostics Market, encompassing current market size, growth trends, and forecasts till 2030.

• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities

• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends

• Identify lucrative investment avenues and expansion opportunities within the Infectious Disease In Vitro Diagnostics Market industry, guided by robust, data-backed analysis.

• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics

• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain

• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics

• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

 

1 Introduction to 2024 Infectious Disease In Vitro Diagnostics Market

1.1 Market Overview

1.2 Quick Facts

1.3 Scope/Objective of the Study

1.4 Market Definition

1.5 Countries and Regions Analyzed

1.6 Units, Currency, and Conversions

1.7 Industry Value Chain

 

2 Research Methodology

2.1 Market Size Estimation

2.2 Sources and Research Methodology

2.3 Data Triangulation

2.4 Assumptions and Limitations

 

3 Executive Summary

3.1 Global Infectious Disease In Vitro Diagnostics Market Size Outlook, $ Million, 2021 to 2030

3.2 Infectious Disease In Vitro Diagnostics Market Outlook by Type, $ Million, 2021 to 2030

3.3 Infectious Disease In Vitro Diagnostics Market Outlook by Product, $ Million, 2021 to 2030

3.4 Infectious Disease In Vitro Diagnostics Market Outlook by Application, $ Million, 2021 to 2030

3.5 Infectious Disease In Vitro Diagnostics Market Outlook by Key Countries, $ Million, 2021 to 2030

 

4 Market Dynamics

4.1 Key Driving Forces of Infectious Disease In Vitro Diagnostics Market Industry

4.2 Key Market Trends in Infectious Disease In Vitro Diagnostics Market Industry

4.3 Potential Opportunities in Infectious Disease In Vitro Diagnostics Market Industry

4.4 Key Challenges in Infectious Disease In Vitro Diagnostics Market Industry

 

5 Market Factor Analysis

5.1 Competitive Landscape

5.1.1 Global Infectious Disease In Vitro Diagnostics Market Share by Company (%), 2023

5.1.2 Product Offerings by Company

5.2 Porter’s Five Forces Analysis

 

6 Growth Outlook Across Scenarios

6.1 Growth Analysis-Case Scenario Definitions

6.2 Low Growth Scenario Forecasts

6.3 Reference Growth Scenario Forecasts

6.4 High Growth Scenario Forecasts

 

7 Global Infectious Disease In Vitro Diagnostics Market Outlook By Segments

7.1 Infectious Disease In Vitro Diagnostics Market Outlook by Segments

By Product

Instruments

Reagents

Software Services

By Technology

Immunoassay

Molecular Diagnostics

-Polymerase Chain Reaction (PCR)

-In Situ Hybridization

-Isothermal Nucleic Acid Amplification Technology (INAAT)

-Chips and Microarrays

-Sequencing & NGS

-Transcription Mediated Amplification

Microbiology

By Application

MRSA

Streptococcus

Clostridium Difficile

VRE

CRE

Respiratory Virus

Candida

TB and Drug-resistant TB

Gastro-intestinal Panel Testing

Chlamydia

Gonorrhea

HPV

HIV

Hepatitis C

Hepatitis B

COVID-19

Others

By Test Location

Point of Care

Central Laboratories

Others

 

8 North America Infectious Disease In Vitro Diagnostics Market Analysis And Outlook To 2030

8.1 Introduction to North America Infectious Disease In Vitro Diagnostics Markets in 2024

8.2 North America Infectious Disease In Vitro Diagnostics Market Size Outlook by Country, 2021-2030

8.2.1 United States

8.2.2 Canada

8.2.3 Mexico

8.3 North America Infectious Disease In Vitro Diagnostics Market size Outlook by Segments, 2021-2030

By Product

Instruments

Reagents

Software Services

By Technology

Immunoassay

Molecular Diagnostics

-Polymerase Chain Reaction (PCR)

-In Situ Hybridization

-Isothermal Nucleic Acid Amplification Technology (INAAT)

-Chips and Microarrays

-Sequencing & NGS

-Transcription Mediated Amplification

Microbiology

By Application

MRSA

Streptococcus

Clostridium Difficile

VRE

CRE

Respiratory Virus

Candida

TB and Drug-resistant TB

Gastro-intestinal Panel Testing

Chlamydia

Gonorrhea

HPV

HIV

Hepatitis C

Hepatitis B

COVID-19

Others

By Test Location

Point of Care

Central Laboratories

Others

 

9 Europe Infectious Disease In Vitro Diagnostics Market Analysis And Outlook To 2030

9.1 Introduction to Europe Infectious Disease In Vitro Diagnostics Markets in 2024

9.2 Europe Infectious Disease In Vitro Diagnostics Market Size Outlook by Country, 2021-2030

9.2.1 Germany

9.2.2 France

9.2.3 Spain

9.2.4 United Kingdom

9.2.4 Italy

9.2.5 Russia

9.2.6 Norway

9.2.7 Rest of Europe

9.3 Europe Infectious Disease In Vitro Diagnostics Market Size Outlook By Segments, 2021-2030

By Product

Instruments

Reagents

Software Services

By Technology

Immunoassay

Molecular Diagnostics

-Polymerase Chain Reaction (PCR)

-In Situ Hybridization

-Isothermal Nucleic Acid Amplification Technology (INAAT)

-Chips and Microarrays

-Sequencing & NGS

-Transcription Mediated Amplification

Microbiology

By Application

MRSA

Streptococcus

Clostridium Difficile

VRE

CRE

Respiratory Virus

Candida

TB and Drug-resistant TB

Gastro-intestinal Panel Testing

Chlamydia

Gonorrhea

HPV

HIV

Hepatitis C

Hepatitis B

COVID-19

Others

By Test Location

Point of Care

Central Laboratories

Others

 

10 Asia Pacific Infectious Disease In Vitro Diagnostics Market Analysis And Outlook To 2030

10.1 Introduction to Asia Pacific Infectious Disease In Vitro Diagnostics Markets in 2024

10.2 Asia Pacific Infectious Disease In Vitro Diagnostics Market Size Outlook by Country, 2021-2030

10.2.1 China

10.2.2 India

10.2.3 Japan

10.2.4 South Korea

10.2.5 Indonesia

10.2.6 Malaysia

10.2.7 Australia

10.2.8 Rest of Asia Pacific

10.3 Asia Pacific Infectious Disease In Vitro Diagnostics Market size Outlook by Segments, 2021-2030

By Product

Instruments

Reagents

Software Services

By Technology

Immunoassay

Molecular Diagnostics

-Polymerase Chain Reaction (PCR)

-In Situ Hybridization

-Isothermal Nucleic Acid Amplification Technology (INAAT)

-Chips and Microarrays

-Sequencing & NGS

-Transcription Mediated Amplification

Microbiology

By Application

MRSA

Streptococcus

Clostridium Difficile

VRE

CRE

Respiratory Virus

Candida

TB and Drug-resistant TB

Gastro-intestinal Panel Testing

Chlamydia

Gonorrhea

HPV

HIV

Hepatitis C

Hepatitis B

COVID-19

Others

By Test Location

Point of Care

Central Laboratories

Others

 

11 South America Infectious Disease In Vitro Diagnostics Market Analysis And Outlook To 2030

11.1 Introduction to South America Infectious Disease In Vitro Diagnostics Markets in 2024

11.2 South America Infectious Disease In Vitro Diagnostics Market Size Outlook by Country, 2021-2030

11.2.1 Brazil

11.2.2 Argentina

11.2.3 Rest of South America

11.3 South America Infectious Disease In Vitro Diagnostics Market size Outlook by Segments, 2021-2030

By Product

Instruments

Reagents

Software Services

By Technology

Immunoassay

Molecular Diagnostics

-Polymerase Chain Reaction (PCR)

-In Situ Hybridization

-Isothermal Nucleic Acid Amplification Technology (INAAT)

-Chips and Microarrays

-Sequencing & NGS

-Transcription Mediated Amplification

Microbiology

By Application

MRSA

Streptococcus

Clostridium Difficile

VRE

CRE

Respiratory Virus

Candida

TB and Drug-resistant TB

Gastro-intestinal Panel Testing

Chlamydia

Gonorrhea

HPV

HIV

Hepatitis C

Hepatitis B

COVID-19

Others

By Test Location

Point of Care

Central Laboratories

Others

 

12 Middle East And Africa Infectious Disease In Vitro Diagnostics Market Analysis And Outlook To 2030

12.1 Introduction to Middle East and Africa Infectious Disease In Vitro Diagnostics Markets in 2024

12.2 Middle East and Africa Infectious Disease In Vitro Diagnostics Market Size Outlook by Country, 2021-2030

12.2.1 Saudi Arabia

12.2.2 UAE

12.2.3 Oman

12.2.4 Rest of Middle East

12.2.5 Egypt

12.2.6 Nigeria

12.2.7 South Africa

12.2.8 Rest of Africa

12.3 Middle East and Africa Infectious Disease In Vitro Diagnostics Market size Outlook by Segments, 2021-2030

By Product

Instruments

Reagents

Software Services

By Technology

Immunoassay

Molecular Diagnostics

-Polymerase Chain Reaction (PCR)

-In Situ Hybridization

-Isothermal Nucleic Acid Amplification Technology (INAAT)

-Chips and Microarrays

-Sequencing & NGS

-Transcription Mediated Amplification

Microbiology

By Application

MRSA

Streptococcus

Clostridium Difficile

VRE

CRE

Respiratory Virus

Candida

TB and Drug-resistant TB

Gastro-intestinal Panel Testing

Chlamydia

Gonorrhea

HPV

HIV

Hepatitis C

Hepatitis B

COVID-19

Others

By Test Location

Point of Care

Central Laboratories

Others

 

13 Company Profiles

13.1  Company Snapshot

13.2 SWOT Profiles

13.3 Products and Services

13.4 Recent Developments

13.5 Financial Profile

List of Companies

Abbott

Becton, Dickinson and Company

bioMérieux SA

Bio-Rad Laboratories Inc

Danaher Corp

F. Hoffmann-La Roche Ltd

Hologic Inc

OraSure Technologies Inc

QIAGEN

Quidel Corp

Siemens Healthineers AG

 

14 Appendix

14.1 Customization Offerings

14.2 Subscription Services

14.3 Related Reports

14.4 Publisher Expertise

Infectious Disease In Vitro Diagnostics Market Segmentation

By Product

Instruments

Reagents

Software Services

 

By Technology

Immunoassay

Molecular Diagnostics

-Polymerase Chain Reaction (PCR)

-In Situ Hybridization

-Isothermal Nucleic Acid Amplification Technology (INAAT)

-Chips and Microarrays

-Sequencing & NGS

-Transcription Mediated Amplification

Microbiology

 

By Application

MRSA

Streptococcus

Clostridium Difficile

VRE

CRE

Respiratory Virus

Candida

TB and Drug-resistant TB

Gastro-intestinal Panel Testing

Chlamydia

Gonorrhea

HPV

HIV

Hepatitis C

Hepatitis B

COVID-19

Others

 

By Test Location

Point of Care

Central Laboratories

Others

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)